Investing in innovation - FutureScot futurescot.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from futurescot.com Daily Mail and Mail on Sunday newspapers.
January 19, 2021 Neurogene has entered into a research collaboration with the University of Edinburgh to advance the development of multiple platform approaches to enable next-generation gene therapies.
The collaboration will provide comprehensive research capabilities to Neurogene, enabling the company and university to accelerate platform approaches that improve upon existing gene therapy technologies focused on neurodevelopmental diseases.
Under the terms of the collaboration, Neurogene will provide financial support for the lab of Stuart Cobb, PhD, at the University of Edinburgh, in exchange for the right to license any applicable intellectual property at agreed upon economic terms. Neurogene will be responsible for late stage preclinical and all clinical development of any products generated under the collaboration.
Circular start-up to repair and recycle cashmere garments
Belinda Dickson and Ross Powell have co-founded the company to help luxury fashion move to a circular economy model while boosting textile skills and jobs in the Scottish Borders.
29th December 2020
A leading Scottish knitwear entrepreneur has joined forces with a University of Edinburgh graduate to launch Cashmere Circle, a service to revive, repair and recycle cashmere garments. Belinda Dickson, founder of Belinda Robertson Cashmere, and Ross Powell have co-founded the company with Edinburgh Innovations’ support to help luxury fashion move to a circular economy model while boosting textile skills and jobs in the Scottish Borders
AN international team including researchers from the University of Edinburgh has been awarded €750,000 (£690,000) to develop artificial intelligence (AI) diagnostic tools for liver disease. The project will look at ways of interpreting patient data to predict when non-alcoholic fatty liver disease (NAFLD) is likely to progress into dangerous conditions such as cirrhosis of the liver and liver cancer. Professor Jonathan Fallowfield and Dr Tim Kendall, from Edinburgh’s Centre for Inflammation Research, will work with a specialist imaging company based in Singapore and two British firms specialising in data management and AI techniques. Around a quarter of people have NAFLD, which affects millions of people worldwide and which is often unnoticed and undiagnosed. There is no way of telling which people with the disease might develop the severe form or progress to cirrhosis.